Natural history of Southeast Asian chronic myeloid leukemia patients with different BCR-ABL gene variants

Acta Haematologica

Volumn 116, Issue 2, 2006, Pages 114-119

  Auewarakul, C U ^a   Huang, S ^b   Yimyam, M ^a   Boonmoh, S ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Ayudhaya Hospital   (Thailand)

Author keywords

BCR ABL gene variant; Chronic myeloid leukemia

Indexed keywords

BCR ABL PROTEIN; PROTEIN TYROSINE KINASE INHIBITOR;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BCR ABL GENE; BLAST CELL CRISIS; CANCER PATIENT; CANCER STAGING; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; FEMALE; GENE; GENETIC VARIABILITY; HIGH RISK PATIENT; HISTORY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHEAST ASIA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FUSION PROTEINS, BCR-ABL; GENES, ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; THAILAND; TRANSPLANTATION, HOMOLOGOUS; VARIATION (GENETICS);

EID: 33747439438     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093641     Document Type: Article

References (26)

1. Rowley JD: Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973;243:290-293.
2. Chissoe SL, Bodenteich A, Wang Y-F, Wang Y-P, Burian D, Clifton SW, Crabtree J, Freeman A, Iyer K, Jian L, Ma Y, McLaury H-J, Pan H-Q, Sarhan OH, Toth S, Wang Z, Zhang G, Heisterkamp N, Groffen J, Roe BA: Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosome translocation. Genomics 1995;27:67-82.
3. Sawyers CL: Chronic myeloid leukemia (review). N Engl J Med 1999;340:1330-1340.
4. Melo JV: The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996;88:2375-2384.
5. 1)-positive and -negative Thai adult acute lymphoid leukemia. Int J Hematol 2003;78:337-343.
6. 1-positive CML patients. Leukemia 1989;3:492-496.
7. Schaefer-Rego K, Dudek H, Popenoe D, Arlin Z, Mears JG, Bank A, Leibowitz D: CML patients in blast crisis have breakpoints localized to a specific region of the BCR. Blood 1987;70:448-455.
8. Eisenberg A, Silver R, Soper L, Arlin Z, Coleman M, Bernhardt B, Benn P: The location of breakpoints within the breakpoint cluster region (bcr) on chromosome 22 in chronic myeloid leukemia. Leukemia 1988;2:642-646.
9. Dyck JA, Bosco JJ: Clinical stage of chronic granulocytic leukaemia and BCR breakpoint location in South-East Asian patients. Br J Haematol 1989;72:64-67.
10. Shepherd P, Suffolk R, Halsey J, Allan N: Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival. Br J Haematol 1995;89:546-554.
11. Rozman C, Urbano-Ispizua A, Cervantes F, Rozman M, Colomer D, Feliz P, Pujades A, Vives Corrons JL: Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia. Leukemia 1995;9:1104-1107.
12. Morris SW, Daniel L, Ahmed CMI, Elias A, Lebowitz P: Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients resenting in early chronic phase. Blood 1990;75:2035-2041.
13. 1-positive chronic myeloid leukaemia. Br J Haematol 1993;84:265-268.
14. Jaubert J, Martial P, Dowding C, Ifrah N, Goldman JM: The position of the M-BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukemia. Br J Haematol 1990;74:30-35.
15. 1-positive CML patients. Blood 1988;72:1237-1241.
16. Udomsakdi-Auewarakul C, Upratya Y, Boonmoh S, Vatanavicharn S: Detection of molecular variants of BCR-ABL gene in bone marrow and blood of patients with chronic myeloid leukemia by reverse-transcriptase polymerase chain reaction (RT-PCR). J Med Assoc Thai 2000;83:928-935.
17. Jootar S, Ungkanont A, Chuncharunee S, Atichartakarn V: Multivariate analysis of prognostic factors in Philadelphia chromosome positive chronic myeloid leukemia: an update of the first series in Thailand. Asian Pac J Allergy Immunol 1996;14:25-30.
18. Leelasiri A, Wuthidejkumjorn N, Srichaikul T: Chronic myeloid leukemia (CML) at Phramongkutklao Hospital. Thai J Hematol Trans Med 2000;10:267-275.
19. Buyse ME, Staquet MJ, Sylvester RJ (eds): Cancer Clinical Trials: Methods and Practice. Oxford, Oxford University Press, 1992.
20. Sokal JE, Cox EB, Baccarini M, Tura S, Gomez GA, Robertson JE, Tso CY, Braun TJ, Clarkson BD, Cervantes F: Prognostic discrimination in 'good-risk' chronic granulocytic leukemia. Blood 1984;63:789-799.
21. Hasford J, Pfirrmann M, Hehlman R, Baccarani M, Guilhot F, Mahon FX, Kluin-Nelemans HC, Ohnishi K, Thaler J, Steegmann JL: Prognosis and prognostic factors for patients with chronic myeloid leukemia: nontransplant therapy. Semin Hematol 2003;40:4-12.
22. Cortes J: Natural history and staging of chronic myelogenous leukemia. Hematol Oncol Clin N Am 2004;18:569-584.
23. Savage DG, Szydlo RM, Goldman JM: Clinical features at diagnosis in 430 patients with chronic myeloid leukemia seen at a referral center over a 16-year period. Br J Haematol 1997;96:111-116.
24. Udomsakdi-Auewarakul C, Promsuwicha O, U-pratya Y, Tocharoentanaphol C, Patanapanyasat K, Issaragrisil S: Immunophenotypic profile of adult acute myeloid leukemia (AML): analysis of 267 cases in Thailand. Asian Pac J Allergy Immunol 2003;21:153-160.
25. Anonymous: Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials. Chronic myeloid leukemia trialists' collaborative group. Br J Haematol 2000;110:573-576.
26. Deininger M, Buchdunger E, Druker BJ: The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 2005;105:2640-2653.